Opportunities in the global market for coronary stents vary by type of stent being developed and the geographic territory in which a manufacturer hopes to compete.
Interesting, sometimes unpredictable dynamics govern why there are greater or lesser opportunities as one considers drug-eluting stents, bare metal stents and absorbable stents, as well as considering the U.S., Europe, Asia/Pacific or any of the remaining markets in the world.
Most importantly, the nature of being competitive in the coronary stents market — indeed, of being competitive in any medtech market — means being willing and able to pursue any and all opportunities, if not in different stent types then at least in global market opportunities. Given partnering options that are available for every sized company, from engineering/design all the way up to and including distribution in almost any market worldwide, pursuing a U.S.-only or Europe-only strategy may severely limit a company’s potential. And with markets becoming increasingly competitive, any limitation in potential may relegate a player to minor market shares and eventual consolidation in the market.
Below are glimpse of the likely distribution of coronary stent unit sales volumes in 2017 by stent type and geography. Although this is aggregate data displayed graphically, it does illustrate that the distribution of coronary stent market varys by geography, setting up very specific opportunities and challenges for market participants.
Source: MedMarket Diligence, LLC; Report #C245, "Worldwide Market for Drug-Eluting, Bare Metal and Other Coronary Stents, 2008-2017".
Purchase for download: Report #C245, "Worldwide Coronary Stents 2009, PDF" — $2,850.00
